Published Date: Mar, 2023 | 250 Pages | Report ID: MRU_229049
Oncology Biosimilars Market Size By Type, By Application, Regional Analysis(Europe, Asia Pacific, America, Middle East And Africa), And Forecasts 2023 - 2030 (Financial Impact Analysis)
ID : MRU_
229049 | Date :
Mar, 2023 | Pages :
250 | Region : Global |
Publisher : MRU
A new research report on the Global Oncology Biosimilars Market titled has recently published by Market Research Update to its humongous database which helps to shape the future of the businesses by making well-informed business decisions.Biosimilar is the identical copy of oncology biologics used for the treatment of cancer and officially approved for the treatment of cancer. These molecules are cost-effective, efficient, and have the same ability as biologics. These molecules are easy to manufacture as compared to biologics and can only be manufactured after patent expiry. Earlier there were various patented biologics available in the market but nowadays most of the patents have expired and few are on the verge of patent expiry. In the past few years, various biosimilars have been approved by FDA for the treatment of various types of cancer such as blood cancer, colorectal cancer, breast cancer, and others. In the near future, it is expected that a few more biosimilars will be introduced in the market thus supporting the growth of the market.
The forecast period 2023-2030 is expected to be great for the Oncology Biosimilars market which will be the face changer for the Pharma & Healthcare industry. The users are increasing day by day which is increasing sales, import, export, revenue, and CAGR values. Summary
The report moreover comprises of the market drivers and limitations which may be gotten from a SWOT assessment of the Oncology Biosimilars market. Top players and types are taking actions alongside inclinations, stock dispatches, acquisitions, consolidations, joint endeavors, and forceful research inside the Oncology Biosimilars market. A change was seen inside the CAGR ranges in the memorable year 2023, the base year 2023 and the CAGR ranges are likewise certain to exchange inside the estimate years 2023-2030.
The cost investigation of the Oncology Biosimilars Market has been performed while keeping in view work cost, producing costs, and crude materials and their market fixation rate, providers, and value pattern. Different factors, for example, downstream purchasers, Supply chain, and sourcing methodology have been evaluated to give a total and top to bottom perspective on the market. Purchasers of the report will likewise be presented to an investigation on market situating with elements, for example, brand procedure, target customer, and value technique mulled over.
The Top Key Players include:
Celltrion
Biocon
Dr. Reddy\'s Laboratories
STADA Arzneimittel AG
Intas Pharmaceuticals
Pfizer
Sandoz International
Teva Pharmaceutical Industries Ltd
Apotex
BIOCAD Global Oncology Biosimilars Market Key Segments: On the Basis of Type:
mAb
Immunomodulators
Hematopoietic Agents
G-CSF
Others On the Basis of Application:
Retail Pharmacies
Hospital Pharmacy
Online Pharmacy
The report conveys the entirety of current realities about market definition, orders, applications, and commitment for the Oncology Biosimilars market that are basic to be victorious inside the market. The principle motivation behind this report is to give a development map with respect to the activities taken by central participants of the Oncology Biosimilars market like item dispatches, joint endeavors, propensities, consolidations, and acquisitions which is influencing the Oncology Biosimilars market and Pharma & Healthcare undertaking in general and furthermore influencing the business, import, fare, income and CAGR values.
By Region:
North America
By Country (US, Canada, Mexico)
By Component
By System
By Application
Western Europe
By Country (Germany, UK, France, Italy, Spain, Rest of Western Europe)
By Component
By System
By Application
Eastern Europe
By Country (Russia, Turkey, Rest of Eastern Europe)
By Component
By System
By Application
Asia Pacific
By Country (China, Japan, India, South Korea, Australia, Rest of Asia Pacific)
By Component
By System
By Application
Middle East
By Country (UAE, Saudi Arabia, Qatar, Iran, Rest of Middle East)
By Component
By System
By Application
Rest of the World
By Region (South America, Africa)
By Component
By System
By Application
The study objectives of global market research report:
To analyze the global Oncology Biosimilars market on the basis of several business verticals such as drivers, restraints, and opportunities
It offers detailed elaboration on the global competitive landscape
To get an informative data of various leading key industries functioning across the global regions
It offers qualitative and quantitative analysis of the global Oncology Biosimilars market
It offers all-inclusive information of global market along with its features, applications, challenges, threats, and opportunities
The major key questions addressed through this innovative research report:
What are the major challenges in front of the global Oncology Biosimilars market?
Who are the key vendors of the global Oncology Biosimilars market?
What are the leading key industries of the global Oncology Biosimilars market?
Which factors are responsible for driving the global Oncology Biosimilars market?
What are the key outcomes of SWOT and Porter\'s five analysis?
What are the major key strategies for enhancing global opportunities?
What are the different effective sales patterns?
What will be the global market size in the forecast period?
COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Oncology Biosimilars market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
Any special requirements about this report, please let us know and we can provide custom report.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Oncology Biosimilars Market Size Growth Rate by Type (2023 - 2030)
1.3.2 mAb
1.3.3 Immunomodulators
1.3.4 Hematopoietic Agents
1.3.5 G-CSF
1.3.6 Others
1.4 Market Segment by Application
1.4.1 Global Oncology Biosimilars Market Share by Application (2023 - 2030)
1.4.2 Retail Pharmacies
1.4.3 Hospital Pharmacy
1.4.4 Online Pharmacy
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncology Biosimilars Market Size
2.1.1 Global Oncology Biosimilars Revenue 2015-2030
2.1.2 Global Oncology Biosimilars Sales 2015-2030
2.2 Oncology Biosimilars Growth Rate by Regions
2.2.1 Global Oncology Biosimilars Sales by Regions 2015-2020
2.2.2 Global Oncology Biosimilars Revenue by Regions 2015-2020
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Oncology Biosimilars Sales by Manufacturers
3.1.1 Oncology Biosimilars Sales by Manufacturers 2015-2020
3.1.2 Oncology Biosimilars Sales Market Share by Manufacturers 2015-2020
3.2 Revenue by Manufacturers
3.2.1 Oncology Biosimilars Revenue by Manufacturers (2018-2022)
3.2.2 Oncology Biosimilars Revenue Share by Manufacturers (2018-2022)
3.2.3 Global Oncology Biosimilars Market Concentration Ratio (CR5 and HHI)
3.3 Oncology Biosimilars Price by Manufacturers
3.4 Key Manufacturers Oncology Biosimilars Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Oncology Biosimilars Market
3.6 Key Manufacturers Oncology Biosimilars Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 mAb Sales and Revenue (2018-2022)
4.1.2 Immunomodulators Sales and Revenue (2018-2022)
4.1.3 Hematopoietic Agents Sales and Revenue (2018-2022)
4.1.4 G-CSF Sales and Revenue (2018-2022)
4.1.5 Others Sales and Revenue (2018-2022)
4.2 Global Oncology Biosimilars Sales Market Share by Type
4.3 Global Oncology Biosimilars Revenue Market Share by Type
4.4 Oncology Biosimilars Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Oncology Biosimilars Sales by Application
6 United States
6.1 United States Oncology Biosimilars Breakdown Data by Company
6.2 United States Oncology Biosimilars Breakdown Data by Type
6.3 United States Oncology Biosimilars Breakdown Data by Application
7 European Union
7.1 European Union Oncology Biosimilars Breakdown Data by Company
7.2 European Union Oncology Biosimilars Breakdown Data by Type
7.3 European Union Oncology Biosimilars Breakdown Data by Application
8 China
8.1 China Oncology Biosimilars Breakdown Data by Company
8.2 China Oncology Biosimilars Breakdown Data by Type
8.3 China Oncology Biosimilars Breakdown Data by Application
9 Rest of World
9.1 Rest of World Oncology Biosimilars Breakdown Data by Company
9.2 Rest of World Oncology Biosimilars Breakdown Data by Type
9.3 Rest of World Oncology Biosimilars Breakdown Data by Application
9.4 Rest of World Oncology Biosimilars Breakdown Data by Countries
9.4.1 Rest of World Oncology Biosimilars Sales by Countries
9.4.2 Rest of World Oncology Biosimilars Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Celltrion
10.1.1 Celltrion Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Oncology Biosimilars
10.1.4 Oncology Biosimilars Product Introduction
10.1.5 Celltrion Recent Development
10.2 Biocon
10.2.1 Biocon Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Oncology Biosimilars
10.2.4 Oncology Biosimilars Product Introduction
10.2.5 Biocon Recent Development
10.3 Dr. Reddy\'s Laboratories
10.3.1 Dr. Reddy\'s Laboratories Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Oncology Biosimilars
10.3.4 Oncology Biosimilars Product Introduction
10.3.5 Dr. Reddy\'s Laboratories Recent Development
10.4 STADA Arzneimittel AG
10.4.1 STADA Arzneimittel AG Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Oncology Biosimilars
10.4.4 Oncology Biosimilars Product Introduction
10.4.5 STADA Arzneimittel AG Recent Development
10.5 Intas Pharmaceuticals
10.5.1 Intas Pharmaceuticals Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Oncology Biosimilars
10.5.4 Oncology Biosimilars Product Introduction
10.5.5 Intas Pharmaceuticals Recent Development
10.6 Pfizer
10.6.1 Pfizer Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Oncology Biosimilars
10.6.4 Oncology Biosimilars Product Introduction
10.6.5 Pfizer Recent Development
10.7 Sandoz International
10.7.1 Sandoz International Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Oncology Biosimilars
10.7.4 Oncology Biosimilars Product Introduction
10.7.5 Sandoz International Recent Development
10.8 Teva Pharmaceutical Industries Ltd
10.8.1 Teva Pharmaceutical Industries Ltd Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Oncology Biosimilars
10.8.4 Oncology Biosimilars Product Introduction
10.8.5 Teva Pharmaceutical Industries Ltd Recent Development
10.9 Apotex
10.9.1 Apotex Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Oncology Biosimilars
10.9.4 Oncology Biosimilars Product Introduction
10.9.5 Apotex Recent Development
10.10 BIOCAD
10.10.1 BIOCAD Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Oncology Biosimilars
10.10.4 Oncology Biosimilars Product Introduction
10.10.5 BIOCAD Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Oncology Biosimilars Sales Channels
11.2.2 Oncology Biosimilars Distributors
11.3 Oncology Biosimilars Customers
12 Market Forecast
12.1 Global Oncology Biosimilars Sales and Revenue Forecast 2023 - 2030
12.2 Global Oncology Biosimilars Sales Forecast by Type
12.3 Global Oncology Biosimilars Sales Forecast by Application
12.4 Oncology Biosimilars Forecast by Regions
12.4.1 Global Oncology Biosimilars Sales Forecast by Regions 2023 - 2030
12.4.2 Global Oncology Biosimilars Revenue Forecast by Regions 2023 - 2030
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
Research Methodology
The Market Research Update offers technology-driven solutions and its full integration in the research process to be skilled at every step. We use diverse assets to produce the best results for our clients. The success of a research project is completely reliant on the research process adopted by the company. Market Research Update assists its clients to recognize opportunities by examining the global market and offering economic insights. We are proud of our extensive coverage that encompasses the understanding of numerous major industry domains.
Market Research Update provide consistency in our research report, also we provide on the part of the analysis of forecast across a gamut of coverage geographies and coverage. The research teams carry out primary and secondary research to implement and design the data collection procedure. The research team then analyzes data about the latest trends and major issues in reference to each industry and country. This helps to determine the anticipated market-related procedures in the future. The company offers technology-driven solutions and its full incorporation in the research method to be skilled at each step.
The Company's Research Process Has the Following Advantages:
Information Procurement
The step comprises the procurement of market-related information or data via different methodologies & sources.
Information Investigation
This step comprises the mapping and investigation of all the information procured from the earlier step. It also includes the analysis of data differences observed across numerous data sources.
Highly Authentic Source
We offer highly authentic information from numerous sources. To fulfills the client’s requirement.
Market Formulation
This step entails the placement of data points at suitable market spaces in an effort to assume possible conclusions. Analyst viewpoint and subject matter specialist based examining the form of market sizing also plays an essential role in this step.
Validation & Publishing of Information
Validation is a significant step in the procedure. Validation via an intricately designed procedure assists us to conclude data-points to be used for final calculations.
We are flexible and responsive startup research firm. We adapt as your research requires change, with cost-effectiveness and highly researched report that larger companies can't match.
Information Safety
Market Research Update ensure that we deliver best reports. We care about the confidential and personal information quality, safety, of reports. We use Authorize secure payment process.
We Are Committed to Quality and Deadlines
We offer quality of reports within deadlines. We've worked hard to find the best ways to offer our customers results-oriented and process driven consulting services.
Our Remarkable Track Record
We concentrate on developing lasting and strong client relationship. At present, we hold numerous preferred relationships with industry leading firms that have relied on us constantly for their research requirements.
Best Service Assured
Buy reports from our executives that best suits your need and helps you stay ahead of the competition.
Customized Research Reports
Our research services are custom-made especially to you and your firm in order to discover practical growth recommendations and strategies. We don't stick to a one size fits all strategy. We appreciate that your business has particular research necessities.
Service Assurance
At Market Research Update, we are dedicated to offer the best probable recommendations and service to all our clients. You will be able to speak to experienced analyst who will be aware of your research requirements precisely.
